IC
BSX icon

IKOS CIF’s Boston Scientific BSX Stock Holding History

IKOS CIF’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$180K Buy
+7,800
New +$186K 1.08% 28
2016
Q1 		– Sell
-7,600
Closed -$138K – 184
2015
Q4 		$138K Buy
+7,600
New +$136K 0.42% 100
2015
Q1 		– Sell
-26,472
Closed -$349K – 237
2014
Q4 		$349K Sell
26,472
-10,970
-29% -$140K 0.59% 77
2014
Q3 		$460K Buy
+37,442
New +$472K 0.66% 59

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

IKOS CIF's BSX Position: Q3 2016 in Review

IKOS CIF opened a new position in Boston Scientific (BSX) in Q3 2016: 7,800 shares worth $180K. The stake represents 1.08% of the portfolio and ranks #28 among its holdings. This is a return to the name: IKOS CIF previously reported a position in BSX as recently as Q4 2015.

IKOS CIF first reported a position in BSX in Q3 2014 and has held it in 4 quarters since. The position peaked at $460K in Q3 2014. 565 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • IKOS CIF held 7,800 shares of Boston Scientific worth $180K as of Q3 2016.
  • Boston Scientific was a new IKOS CIF position in Q3 2016.
  • Boston Scientific made up 1.08% of IKOS CIF's portfolio in Q3 2016, its #28 holding.
  • IKOS CIF first reported a position in Boston Scientific in Q3 2014 and has held it in 4 quarters since.
  • IKOS CIF's Boston Scientific position peaked at $460K in Q3 2014.
  • 565 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.